Major Announcements - Zhaoyi Innovation plans to use 500 million CNY of A-share fundraising to increase capital in its wholly-owned subsidiaries for the implementation of the DRAM project [1] - Haiguang Information's mid-2025 profit distribution plan includes a cash dividend of 0.09 CNY per share, totaling 209 million CNY [2] - *ST Biology has terminated the major asset restructuring plan to acquire 51% of Hunan Huize Biomedical Technology Co., Ltd. [3] - Fosun Pharma intends to spin off its subsidiary Fosun Antigen for independent listing on the Hong Kong Stock Exchange [4] - Jingchen Co. has set the inquiry transfer price at 82.85 CNY per share for the transfer of 13.1 million shares [5] Performance Forecasts - Zhaoyi Innovation expects a net profit of approximately 1.61 billion CNY for 2025, a year-on-year increase of about 46% [9] - Longying Precision anticipates a net profit decrease of 17.70% to 29.36% for 2025, estimating between 545 million CNY and 635 million CNY [9] - Ruichuang Micro-Nano forecasts a net profit of around 1.1 billion CNY for 2025, representing a 93% increase [10] - Nanjing Bank projects a net profit of 21.81 billion CNY for 2025, an 8.08% increase year-on-year [11] - Zhongyuan Co. expects a net profit increase of 80% to 105% for 2025, estimating between 139 million CNY and 158 million CNY [12] - Qiangyi Co. anticipates a net profit increase of 57.87% to 71.17% for 2025, estimating between 368 million CNY and 399 million CNY [13] - Liard expects a net profit of 300 million CNY to 380 million CNY for 2025, turning from a loss of 889 million CNY in the previous year [14] - Daheng Technology forecasts a net profit of approximately 106 million CNY for 2025, also turning from a loss [16] - Dongfeng Co. anticipates a net loss of 390 million CNY to 480 million CNY for 2025 [17] - Qing Song Co. expects a net profit increase of 137.73% to 201.74% for 2025, estimating between 130 million CNY and 165 million CNY [18] - SIRUI Co. forecasts a net profit of 165 million CNY to 184 million CNY for 2025, turning from a loss [19] - Shengmei Shanghai expects a revenue increase of 18.91% to 22.47% for 2025, estimating between 6.68 billion CNY and 6.88 billion CNY [20] - Yijun Co. anticipates a net loss of 11 million CNY to 14 million CNY for 2025 [21] - Saint Yuan Environmental Protection expects a net profit increase of 31.79% to 59.24% for 2025, estimating between 240 million CNY and 290 million CNY [22] - Lijun Co. forecasts a net profit decrease of 45.05% to 60.03% for 2025, estimating between 4.8 million CNY and 6.6 million CNY [23] - Xingqi Eye Medicine expects a net profit increase of 95.82% to 121.56% for 2025, estimating between 662 million CNY and 749 million CNY [25] - Beidou Star expects a net loss of 230 million CNY to 290 million CNY for 2025, reducing losses compared to the previous year [26] - Yiling Pharmaceutical anticipates a net profit of 1.2 billion CNY to 1.3 billion CNY for 2025, turning from a loss of 725 million CNY [27] - Zhijiang Bio forecasts a net loss of 32 million CNY to 47 million CNY for 2025, reducing losses compared to the previous year [28] - Yema Battery expects a net profit decrease of 58% to 70% for 2025, estimating between 45.83 million CNY and 64.17 million CNY [29] - Yunmei Energy anticipates a net loss of 410 million CNY to 470 million CNY for 2025 [30] - Yingfang Micro expects a net loss of 69 million CNY to 97 million CNY for 2025 [31] - Guanghua Technology forecasts a net profit of 85 million CNY to 120 million CNY for 2025, turning from a loss [33] Share Buybacks - Hengyi Petrochemical plans to repurchase shares worth 500 million CNY to 1 billion CNY [34] - Yunyi Electric plans to repurchase shares worth 100 million CNY to 150 million CNY [34] - Xidun Pharmaceutical plans to repurchase shares worth 25 million CNY to 50 million CNY [35]

光华科技（002741）(002741.SZ)披露2025年年度业绩预告，公司预计归属于上市公司股东的净利润 8500万元至1.2亿元，扭亏为盈;扣除非经常性损益后的净利润8000万元至1.15亿元。 ...

智通财经APP讯，光华科技(002741.SZ)披露2025年年度业绩预告，公司预计归属于上市公司股东的净利 润8500万元至1.2亿元，扭亏为盈;扣除非经常性损益后的净利润8000万元至1.15亿元。 ...

格隆汇1月22日｜光华科技发布2025年度业绩预告，预计归属于上市公司股东的净利润为8500万元–1.2 亿元，上年同期为亏损20494.72万元。报告期内，公司加大专用化学品、PCB板块业务拓展，调整新能 源板块发展战略实现减亏，持续推进降本增效，提升经营效率。 ...

南财智讯1月22日电，光华科技发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 8,500万元—12,000万元，同比扭亏；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润 为8,000万元—11,500万元，同比扭亏。报告期内，公司持续加大专用化学品、PCB板块业务的拓展力 度，进一步扩大公司在专用化学品、PCB领域的领先优势；通过调整新能源板块发展战略及经营计划， 新能源板块实现减亏；通过持续推进降本增效工作，不断提升产品竞争力，全面提升经营效率，保障了 公司的稳步发展。本次业绩预测已对部分资产因闲置等原因可能产生的减值进行测试并计提减值准备。 ...

Core Viewpoint - The company, Guanghua Technology, is expected to turn a profit in 2025, with a projected net profit attributable to shareholders ranging from 85 million to 120 million yuan, compared to a loss of 204.9472 million yuan in the same period last year [1] Financial Performance - The projected net profit after deducting non-recurring items is estimated to be between 80 million and 115 million yuan, compared to a loss of 164.155 million yuan in the previous year [1] - The basic earnings per share are forecasted to be between 0.18 yuan and 0.26 yuan, while the previous year recorded a loss of 0.51 yuan per share [1] Business Development - The improvement in performance is attributed to the company's expansion into specialized chemicals and PCB (Printed Circuit Board) business, as well as a reduction in losses in the new energy sector [1] - The company is also focusing on cost reduction and efficiency enhancement initiatives [1]

2025 年年度业绩预告 证券代码：002741 证券简称：光华科技 公告编号：2026-002 广东光华科技股份有限公司 二、与会计师事务所沟通情况 本次业绩预告未经会计师事务所审计。公司已就本次业绩预告情况与年报审 计会计师事务所进行沟通，公司与会计师事务所对本次业绩预告内容不存在重大 分歧。 三、业绩变动原因说明 报告期内，公司持续加大专用化学品、PCB 板块业务的拓展力度，进一步扩 大公司在专用化学品、PCB 领域的领先优势；通过调整新能源板块发展战略及经 营计划，新能源板块实现减亏；通过持续推进降本增效工作，不断提升产品竞争 力，全面提升经营效率，保障了公司的稳步发展。 本次业绩预测已对部分资产因闲置等原因可能产生的减值进行测试并计提 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1．业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日 2．预计的经营业绩：扭亏为盈 2025 年度（2025 年 1 月 1 日至 2025 年 12 月 31 日）业绩预计情况： | 项 | 目 | | 本报告期 | ...

Core Insights - On January 16, 2026, the China Materials and Testing Standardization Committee successfully held a group standard review meeting, marking the transition of two standards, "Copper Surface Bonding Performance Specification for High-Speed Printed Circuit Boards" and "Deep Plating Capability Testing Method for Printed Circuit Board Via," from drafting to the preparation stage for formal release [2][19] Group 1: Standards Development - The two standards fill a gap in the testing and evaluation criteria for high-speed printed circuit boards, providing essential technical support and quality assessment for high-end electronic circuit manufacturing [2][19] - The expert group, consisting of representatives from various industry associations and research institutions, conducted a thorough review of the standards, focusing on technical indicators, testing methods, and text expression [4][21] - The successful approval of these standards signifies a move towards more precise and standardized practices in the electronic circuit chemical industry, promoting process optimization and quality upgrades in the high-end PCB sector [6][23] Group 2: Industry Impact - The new standards will provide normative evaluation requirements for electronic circuit chemicals used in AI server PCBs, high-speed PCBs, and multilayer PCBs, enhancing China's standard-setting authority in the global high-speed PCB market [6][23] - Guangdong Guanghua Technology Co., Ltd., founded in 1980, aims to lead in high-performance electronic chemicals and specialized chemical services, contributing to national technological innovation and high-quality industry development [8][25]

（文章来源：证券日报） 证券日报网讯 1月21日，光华科技在互动平台回答投资者提问时表示，公司使用暂时闲置募集资金进行 现金管理，是在确保公司募投项目所需资金正常使用的前提下进行的，不会影响公司募集资金投资项目 建设和日常业务的正常开展。 ...

光华科技（002741.SZ）1月21日在投资者互动平台表示，该项目正有序推进中，未涉及固态电池材料产 品。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：请问公司达州项目公告中提到过的主要生产产品除了 磷酸铁，碳酸锂这两种，还有没有涉及到具体的固态电池材料产品？ ...